{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:43:43Z","timestamp":1789667023854,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CS-2018-18-ST2-014"],"award-info":[{"award-number":["CS-2018-18-ST2-014"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S003118\/1"],"award-info":[{"award-number":["MR\/S003118\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["SGL015\/1020"],"award-info":[{"award-number":["SGL015\/1020"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L017105\/1"],"award-info":[{"award-number":["MR\/L017105\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Clozapine is the most effective intervention for treatment-resistant schizophrenia (TRS). Several studies report ethnic disparities in clozapine treatment. However, few studies restrict analyses to TRS cohorts alone or address confounding by benign ethnic neutropenia. This study investigates ethnic equity in access to clozapine treatment for people with treatment-resistant schizophrenia spectrum disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study, using information from 11\u00a0years of clinical records (2007\u20132017) from the South London and Maudsley NHS Trust. We identified a cohort of service-users with TRS using a validated algorithm. We investigated associations between ethnicity and clozapine treatment, adjusting for sociodemographic factors, psychiatric multi-morbidity, substance misuse, neutropenia, and service-use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 2239 cases of TRS, Black service-users were less likely to be receive clozapine compared with White British service-users after adjusting for confounders (Black African aOR\u2009=\u20090.49, 95% CI [0.33, 0.74],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; Black Caribbean aOR\u2009=\u20090.64, 95% CI [0.43, 0.93],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019; Black British aOR\u2009=\u20090.61, 95% CI [0.41, 0.91],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). It was additionally observed that neutropenia was not related to treatment with clozapine. Also, a detention under the Mental Health Act was negatively associated clozapine receipt, suggesting people with TRS who were detained are less likely to be treated with clozapine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Black service-users with TRS were less likely to receive clozapine than White British service-users. Considering the protective effect of treatment with clozapine, these inequities may place Black service-users at higher risk for hospital admissions and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00127-022-02257-3","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T12:40:33Z","timestamp":1646397633000},"page":"1341-1355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8876-4595","authenticated-orcid":false,"given":"Daniela Fonseca","family":"de Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"India","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3182-905X","authenticated-orcid":false,"given":"Giouliana","family":"Kadra-Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-3614","authenticated-orcid":false,"given":"Megan","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Broadbent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-8788","authenticated-orcid":false,"given":"Rashmi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-295X","authenticated-orcid":false,"given":"Johnny","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9550-3895","authenticated-orcid":false,"given":"Aviv","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-1635","authenticated-orcid":false,"given":"Mizanur","family":"Khondoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-1018","authenticated-orcid":false,"given":"James H.","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-2144","authenticated-orcid":false,"given":"Kamaldeep","family":"Bhui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-244X","authenticated-orcid":false,"given":"Richard D.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1526-4637.2011.01310.x","volume":"13","author":"SH Meghani","year":"2012","unstructured":"Meghani SH, Byun E, Gallagher RM (2012) Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med 13:150\u2013174. https:\/\/doi.org\/10.1111\/j.1526-4637.2011.01310.x","journal-title":"Pain Med"},{"key":"2257_CR2","doi-asserted-by":"publisher","first-page":"e011938","DOI":"10.1136\/bmjopen-2016-011938","volume":"6","author":"RJ Pinder","year":"2016","unstructured":"Pinder RJ, Ferguson J, M\u00f8ller H (2016) Minority ethnicity patient satisfaction and experience: results of the National Cancer Patient Experience Survey in England. BMJ Open 6:e011938. https:\/\/doi.org\/10.1136\/bmjopen-2016-011938","journal-title":"BMJ Open"},{"key":"2257_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2393-13-196","volume":"13","author":"J Henderson","year":"2013","unstructured":"Henderson J, Gao H, Redshaw M (2013) Experiencing maternity care: the care received and perceptions of women from different ethnic groups. BMC Pregnancy Childb 13:196. https:\/\/doi.org\/10.1186\/1471-2393-13-196","journal-title":"BMC Pregnancy Childb"},{"key":"2257_CR4","unstructured":"McManus S, Bebbington P, Jenkins R, Brugha T (2016) Mental health and wellbeing in England: adult psychiatric morbidity survey 2014. In: NHS Digit. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/556596\/apms-2014-full-rpt.pdf"},{"key":"2257_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-020-01603-7","author":"Z Chui","year":"2020","unstructured":"Chui Z, Gazard B, MacCrimmon S et al (2020) Inequalities in referral pathways for young people accessing secondary mental health services in south east London. Eur Child Adolesc Psychiatry. https:\/\/doi.org\/10.1007\/s00787-020-01603-7","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2257_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12916-018-1201-9","volume":"16","author":"K Halvorsrud","year":"2018","unstructured":"Halvorsrud K, Nazroo J, Otis M et al (2018) Ethnic inequalities and pathways to care in psychosis in England: a systematic review and meta-analysis. BMC Med 16:223. https:\/\/doi.org\/10.1186\/s12916-018-1201-9","journal-title":"BMC Med"},{"key":"2257_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1035-5","volume":"16","author":"J Das-Munshi","year":"2018","unstructured":"Das-Munshi J, Bhugra D, Crawford MJ (2018) Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study. BMC Med 16:1\u201310. https:\/\/doi.org\/10.1186\/s12916-018-1035-5","journal-title":"BMC Med"},{"key":"2257_CR8","doi-asserted-by":"publisher","first-page":"e034913","DOI":"10.1136\/bmjopen-2019-034913","volume":"10","author":"RM Morris","year":"2020","unstructured":"Morris RM, Sellwood W, Edge D et al (2020) Ethnicity and impact on the receipt of cognitive\u2013behavioural therapy in people with psychosis or bipolar disorder: an English cohort study. BMJ Open 10:e034913. https:\/\/doi.org\/10.1136\/bmjopen-2019-034913","journal-title":"BMJ Open"},{"key":"2257_CR9","unstructured":"NICE (2014) Psychosis and schizophrenia in adults: prevention and management. https:\/\/www.nice.org.uk\/guidance\/cg178"},{"key":"2257_CR10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2021.61","author":"D Siskind","year":"2021","unstructured":"Siskind D, Orr S, Sinha S et al (2021) Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry. https:\/\/doi.org\/10.1192\/bjp.2021.61","journal-title":"Br J Psychiatry"},{"key":"2257_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Agid O et al (2017) Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry 174:216\u2013229. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16050503","journal-title":"Am J Psychiatry"},{"key":"2257_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"D Siskind","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S (2016) Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry 209:385\u2013392. https:\/\/doi.org\/10.1192\/bjp.bp.115.177261","journal-title":"Br J Psychiatry"},{"key":"2257_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/schbul\/sbj067","volume":"32","author":"SW Lewis","year":"2005","unstructured":"Lewis SW, Barnes TRE, Davies L et al (2005) Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 32:715\u2013723. https:\/\/doi.org\/10.1093\/schbul\/sbj067","journal-title":"Schizophr Bull"},{"key":"2257_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/acps.12700","volume":"135","author":"R Land","year":"2017","unstructured":"Land R, Siskind D, McArdle P et al (2017) The impact of clozapine on hospital use: a systematic review and meta-analysis. Acta Psychiatr Scand 135:296\u2013309. https:\/\/doi.org\/10.1111\/acps.12700","journal-title":"Acta Psychiatr Scand"},{"key":"2257_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/0269881118817387","volume":"33","author":"J Kesserwani","year":"2019","unstructured":"Kesserwani J, Kadra G, Downs J et al (2019) Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine. J Psychopharmacol 33:449\u2013458. https:\/\/doi.org\/10.1177\/0269881118817387","journal-title":"J Psychopharmacol"},{"key":"2257_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12989","author":"J Cho","year":"2018","unstructured":"Cho J, Hayes RD, Jewell A et al (2018) Clozapine and all\u2010cause mortality in treatment\u2010resistant schizophrenia: a historical cohort study. Acta Psychiatr Scand. https:\/\/doi.org\/10.1111\/acps.12989","journal-title":"Acta Psychiatr Scand"},{"key":"2257_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/schbul\/sby052","volume":"45","author":"JM Vermeulen","year":"2019","unstructured":"Vermeulen JM, van Rooijen G, van de Kerkhof MPJ et al (2019) Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1\u201312.5 years. Schizophr Bull 45:315\u2013329. https:\/\/doi.org\/10.1093\/schbul\/sby052","journal-title":"Schizophr Bull"},{"key":"2257_CR18","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.160.10.1817","volume":"160","author":"LA Copeland","year":"2003","unstructured":"Copeland LA, Zeber JE, Valenstein M, Blow FC (2003) Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry 160:1817\u20131822. https:\/\/doi.org\/10.1176\/appi.ajp.160.10.1817","journal-title":"Am J Psychiatry"},{"key":"2257_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1176\/appi.ps.57.1.133","volume":"57","author":"JB Mallinger","year":"2006","unstructured":"Mallinger JB, Fisher SG, Brown T, Lamberti JS (2006) Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv 57:133\u2013136. https:\/\/doi.org\/10.1176\/appi.ps.57.1.133","journal-title":"Psychiatr Serv"},{"key":"2257_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2020.07.023","volume":"224","author":"JC Williams","year":"2020","unstructured":"Williams JC, Harowitz J, Glover J et al (2020) Systematic review of racial disparities in clozapine prescribing. Schizophr Res 224:11\u201318. https:\/\/doi.org\/10.1016\/j.schres.2020.07.023","journal-title":"Schizophr Res"},{"key":"2257_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855995","author":"K Beck","year":"2019","unstructured":"Beck K, McCutcheon R, Stephenson L et al (2019) Prevalence of treatment-resistant psychoses in the community: a naturalistic study. J Psychopharmacol. https:\/\/doi.org\/10.1177\/0269881119855995","journal-title":"J Psychopharmacol"},{"key":"2257_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.4088\/JCP.v67n0911","volume":"67","author":"DL Kelly","year":"2006","unstructured":"Kelly DL, Dixon LB, Kreyenbuhl JA et al (2006) Clozapine utilization and outcomes by race in a public mental health system: 1994\u20132000. J Clin Psychiatry 67:1404\u20131411. https:\/\/doi.org\/10.4088\/JCP.v67n0911","journal-title":"J Clin Psychiatry"},{"key":"2257_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1176\/appi.ajp.159.4.567","volume":"159","author":"E Kuno","year":"2002","unstructured":"Kuno E, Rothbard AB (2002) Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 159:567\u2013572. https:\/\/doi.org\/10.1176\/appi.ajp.159.4.567","journal-title":"Am J Psychiatry"},{"key":"2257_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1176\/appi.ps.201300180","volume":"65","author":"TS Stroup","year":"2014","unstructured":"Stroup TS, Gerhard T, Crystal S et al (2014) Geographic and clinical variation in clozapine use in the United States. Psychiatr Serv 65:186\u2013192. https:\/\/doi.org\/10.1176\/appi.ps.201300180","journal-title":"Psychiatr Serv"},{"key":"2257_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1176\/appi.ps.201100435","volume":"63","author":"JI Manuel","year":"2012","unstructured":"Manuel JI, Essock SM, Wu Y et al (2012) Factors associated with initiation on clozapine and on other antipsychotics among medicaid enrollees. Psychiatr Serv 63:1146\u20131149. https:\/\/doi.org\/10.1176\/appi.ps.201100435","journal-title":"Psychiatr Serv"},{"key":"2257_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0269881107065899","volume":"21","author":"A Connolly","year":"2007","unstructured":"Connolly A, Rogers P, Taylor D (2007) Antipsychotic prescribing quality and ethnicity\u2014a study of hospitalized patients in south east London. J Psychopharmacol 21:191\u2013197. https:\/\/doi.org\/10.1177\/0269881107065899","journal-title":"J Psychopharmacol"},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1017\/S0033291716002014","volume":"46","author":"J Lally","year":"2016","unstructured":"Lally J, Ajnakina O, Di Forti M et al (2016) Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychol Med 46:3231\u20133240. https:\/\/doi.org\/10.1017\/S0033291716002014","journal-title":"Psychol Med"},{"key":"2257_CR28","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.4088\/JCP.15r10085","volume":"77","author":"P Manu","year":"2016","unstructured":"Manu P, Sarvaiya N, Rogozea LM et al (2016) Benign ethnic neutropenia and clozapine use: a systematic review of the evidence and treatment recommendations. J Clin Psychiatry 77:e909\u2013e916. https:\/\/doi.org\/10.4088\/JCP.15r10085","journal-title":"J Clin Psychiatry"},{"key":"2257_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1192\/bjb.2018.67","volume":"43","author":"S Farooq","year":"2019","unstructured":"Farooq S, Choudry A, Cohen D et al (2019) Barriers to using clozapine in treatment-resistant schizophrenia: systematic review. BJPsych Bull 43:8\u201316. https:\/\/doi.org\/10.1192\/bjb.2018.67","journal-title":"BJPsych Bull"},{"key":"2257_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.12898","volume":"138","author":"N Myles","year":"2018","unstructured":"Myles N, Myles H, Xia S et al (2018) Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand 138:101\u2013109. https:\/\/doi.org\/10.1111\/acps.12898","journal-title":"Acta Psychiatr Scand"},{"key":"2257_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-244X-9-51","volume":"9","author":"R Stewart","year":"2009","unstructured":"Stewart R, Soremekun M, Perera G et al (2009) The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 9:51. https:\/\/doi.org\/10.1186\/1471-244X-9-51","journal-title":"BMC Psychiatry"},{"key":"2257_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-008721","volume":"6","author":"G Perera","year":"2016","unstructured":"Perera G, Broadbent M, Callard F et al (2016) Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource. BMJ Open 6:1\u201322. https:\/\/doi.org\/10.1136\/bmjopen-2015-008721","journal-title":"BMJ Open"},{"key":"2257_CR33","unstructured":"CRIS NLP Service (2021) Library of production-ready applications, v1.6. https:\/\/www.maudsleybrc.nihr.ac.uk\/facilities\/clinical-record-interactive-search-cris\/cris-natural-language-processing\/"},{"key":"2257_CR34","doi-asserted-by":"publisher","first-page":"e012012","DOI":"10.1136\/bmjopen-2016-012012","volume":"7","author":"RG Jackson","year":"2017","unstructured":"Jackson RG, Patel R, Jayatilleke N et al (2017) Natural language processing to extract symptoms of severe mental illness from clinical text: the Clinical Record Interactive Search Comprehensive Data Extraction (CRIS-CODE) project. BMJ Open 7:e012012. https:\/\/doi.org\/10.1136\/bmjopen-2016-012012","journal-title":"BMJ Open"},{"key":"2257_CR35","unstructured":"Kadra-Scalzo G, Freitas DF, Agbedjro D et al (submitted) Predicting treatment resistance in schizophrenia using clinical and demographic information: a predictor model using data from electronic health records. J Schizophrenia Res"},{"key":"2257_CR36","unstructured":"Department for Communities and Local Government (2011) The English indices of deprivation 2010. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/6871\/1871208.pdf"},{"key":"2257_CR37","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","volume":"6","author":"R Patel","year":"2016","unstructured":"Patel R, Wilson R, Jackson R et al (2016) Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open 6:e009888. https:\/\/doi.org\/10.1136\/bmjopen-2015-009888","journal-title":"BMJ Open"},{"key":"2257_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1192\/bjp.174.5.432","volume":"174","author":"JK Wing","year":"1999","unstructured":"Wing JK, Curtis RH, Beevor AS (1999) Health of the Nation Outcome Scales (HoNOS). Br J Psychiatry 174:432\u2013434. https:\/\/doi.org\/10.1192\/bjp.174.5.432","journal-title":"Br J Psychiatry"},{"key":"2257_CR39","unstructured":"HM Government (1983) Mental Health Act 1983. http:\/\/www.legislation.gov.uk\/ukpga\/1983\/20\/contents"},{"key":"2257_CR40","unstructured":"StataCorp (2017) Stata statistical software: release 15"},{"key":"2257_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0269881110364267","volume":"25","author":"E Whiskey","year":"2011","unstructured":"Whiskey E, Olofinjana O, Taylor D (2011) The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study. J Psychopharmacol 25:842\u2013845. https:\/\/doi.org\/10.1177\/0269881110364267","journal-title":"J Psychopharmacol"},{"key":"2257_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2215-0366(19)30027-6","volume":"6","author":"P Barnett","year":"2019","unstructured":"Barnett P, Mackay E, Matthews H et al (2019) Ethnic variations in compulsory detention under the Mental Health Act: a systematic review and meta-analysis of international data. Lancet Psychiatry 6:8\u201310. https:\/\/doi.org\/10.1016\/S2215-0366(19)30027-6","journal-title":"Lancet Psychiatry"},{"key":"2257_CR43","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S2045796020001043","volume":"30","author":"V Lawrence","year":"2021","unstructured":"Lawrence V, McCombie C, Nikolakopoulos G, Morgan C (2021) Ethnicity and power in the mental health system: experiences of white British and black Caribbean people with psychosis. Epidemiol Psychiatr Sci 30:e12. https:\/\/doi.org\/10.1017\/S2045796020001043","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2257_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","volume":"201","author":"H Verdoux","year":"2018","unstructured":"Verdoux H, Quiles C, Bachmann CJ, Siskind D (2018) Prescriber and institutional barriers and facilitators of clozapine use: a systematic review. Schizophr Res 201:10\u201319. https:\/\/doi.org\/10.1016\/j.schres.2018.05.046","journal-title":"Schizophr Res"},{"key":"2257_CR45","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1111\/j.1467-789X.2010.00829.x","volume":"12","author":"AM El-Sayed","year":"2011","unstructured":"El-Sayed AM, Scarborough P, Galea S (2011) Ethnic inequalities in obesity among children and adults in the UK: a systematic review of the literature. Obes Rev 12:e516\u2013e534. https:\/\/doi.org\/10.1111\/j.1467-789X.2010.00829.x","journal-title":"Obes Rev"},{"key":"2257_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.jhh.1002126","volume":"21","author":"GYH Lip","year":"2007","unstructured":"Lip GYH, Barnett AH, Bradbury A et al (2007) Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 21:183\u2013211. https:\/\/doi.org\/10.1038\/sj.jhh.1002126","journal-title":"J Hum Hypertens"},{"key":"2257_CR47","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/jech.2009.089409","volume":"63","author":"JY Nazroo","year":"2009","unstructured":"Nazroo JY, Falaschetti E, Pierce M, Primatesta P (2009) Ethnic inequalities in access to and outcomes of healthcare: analysis of the Health Survey for England. J Epidemiol Community Health 63:1022\u20131027. https:\/\/doi.org\/10.1136\/jech.2009.089409","journal-title":"J Epidemiol Community Health"},{"key":"2257_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3371\/CSRP.KNMG.111717","volume":"12","author":"KL Nemani","year":"2019","unstructured":"Nemani KL, Greene MC, Ulloa M et al (2019) Clozapine, diabetes mellitus, cardiovascular risk and mortality: results of a 21-year naturalistic study in patients with schizophrenia and schizoaffective disorder. Clin Schizophr Relat Psychoses 12:168\u2013176. https:\/\/doi.org\/10.3371\/CSRP.KNMG.111717","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"2257_CR49","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J et al (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394:939\u2013951. https:\/\/doi.org\/10.1016\/S0140-6736(19)31135-3","journal-title":"Lancet"},{"key":"2257_CR50","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1017\/S1461145712001241","volume":"16","author":"WW Fleischhacker","year":"2013","unstructured":"Fleischhacker WW, Siu CO, Bod\u00e9n R et al (2013) Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J Neuropsychopharmacol 16:987\u2013995. https:\/\/doi.org\/10.1017\/S1461145712001241","journal-title":"Int J Neuropsychopharmacol"},{"key":"2257_CR51","unstructured":"Cabinet Office (2018) Race disparity audit. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/686071\/Revised_RDA_report_March_2018.pdf"},{"key":"2257_CR52","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2105\/AJPH.2011.300601","volume":"102","author":"JF Dovidio","year":"2012","unstructured":"Dovidio JF, Fiske ST (2012) Under the radar: how unexamined biases in decision-making processes in clinical interactions can contribute to health care disparities. Am J Public Health 102:945\u2013952. https:\/\/doi.org\/10.2105\/AJPH.2011.300601","journal-title":"Am J Public Health"},{"key":"2257_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/1467-9566.13001","volume":"42","author":"JY Nazroo","year":"2020","unstructured":"Nazroo JY, Bhui KS, Rhodes J (2020) Where next for understanding race\/ethnic inequalities in severe mental illness? Structural, interpersonal and institutional racism. Sociol Health Illn 42:262\u2013276. https:\/\/doi.org\/10.1111\/1467-9566.13001","journal-title":"Sociol Health Illn"},{"key":"2257_CR54","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.2105\/AJPH.2015.302903","volume":"105","author":"WJ Hall","year":"2015","unstructured":"Hall WJ, Chapman MV, Lee KM et al (2015) Implicit racial\/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review. Am J Public Health 105:e60\u2013e76. https:\/\/doi.org\/10.2105\/AJPH.2015.302903","journal-title":"Am J Public Health"},{"key":"2257_CR55","unstructured":"ONS (Office for National Statistics) (2011) Nomis\u2014official labour market statistics. https:\/\/www.nomisweb.co.uk\/census\/2011\/ks201ew"},{"key":"2257_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2016-015297","volume":"7","author":"C Colling","year":"2017","unstructured":"Colling C, Evans L, Broadbent M et al (2017) Identification of the delivery of cognitive behavioural therapy for psychosis (CBTp) using a cross-sectional sample from electronic health records and open-text information in a large UK-based mental health case register. BMJ Open 7:1\u201310. https:\/\/doi.org\/10.1136\/bmjopen-2016-015297","journal-title":"BMJ Open"},{"key":"2257_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/fampra\/cmi113","volume":"23","author":"E Scheppers","year":"2006","unstructured":"Scheppers E (2006) Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract 23:325\u2013348. https:\/\/doi.org\/10.1093\/fampra\/cmi113","journal-title":"Fam Pract"},{"key":"2257_CR58","unstructured":"RCPsych (Royal College of Psychiatrists) (2021) Six in ten Black, Asian and Minority Ethnic psychiatrists have experienced racism at work. https:\/\/www.rcpsych.ac.uk\/news-and-features\/latest-news\/detail\/2021\/01\/21\/six-in-ten-black-asian-and-minority-ethnic-psychiatrists-have-experienced-racism-at-work"},{"key":"2257_CR59","unstructured":"RCPsych (Royal College of Psychiatrists) (2021) RCPsych Equality Action Plan 2021\u201323. https:\/\/www.rcpsych.ac.uk\/about-us\/equality-diversity-and-inclusion\/equality-action-plan"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-022-02257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-022-02257-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-022-02257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T03:07:45Z","timestamp":1656558465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-022-02257-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s00127-022-02257-3","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors completed the ICMJE uniform disclosure. During the conduction of the study, DFdF, GKS, and RH reported receiving funds from the NIHR Maudsley Biomedical Research Centre. For other activities outside the submitted work: DFdF reported research funding from the UK Department of Health and Social Care, Janssen Research & Development LLC, and H. Lundbeck A\/S; GKS received research funding from Janssen Research & Development LLC and H. Lundbeck A\/S; RP reports grants from the NIHR,\u00a0the Medical Research Council, the Academy of Medical Sciences, and Janssen-Cilag, and personal fees from Induction Healthcare and from Holmusk; JHM received research funding from H. Lundbeck A\/S and the Medical Research Council; and RH received research funding from Janssen Research & Development LLC, H. Lundbeck A\/S, Medical Research Council and from the UK Department of Health and Social Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"CRIS dataset received approval from the Oxford C Research Ethics Committee (18\/SC\/0372). All projects using the CRIS dataset are submitted for approval to an oversight committee led by service-users.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}